Table 1.
Overall characteristics of the study population before intervention (Mean±SD)/ (Median (IQR))
| Variables | Groups | |||
|---|---|---|---|---|
|
Curcumin
N=27 |
Placebo
N=29 |
|||
| Dependent | ALT (IU/L) | 73.27±29.70 | 74.25±29.74 | |
| AST (IU/L) | 49.93±22.73 | 50.37±17.47 | ||
| ALP (IU/L) | 203.10±68.52 | 212.66±46.03 | ||
| Independent | Anthropometric | BMI (kg/m2) | 29.90±4.58 | 29.68±4.61 |
| Sex | Male (No/%) | 21(78%) | 23(79%) | |
| Demographic | Weight(kg) | 82.34±13.62 | 83.79±16.67 | |
| Age(y) | 43.27±8.63 | 36.85±10.83 | ||
| Biochemical | TG (mg/dl) (median (IQR)) | 165.37(101-190) | 173.55(103-187) | |
| CHOL (mg/dl) | 195.03±34.00 | 186.22±33.25 | ||
| HDL (mg/dl) | 45.51±10.59 | 42.24±13.08 | ||
| LDL (mg/dl) | 119.20±26.62 | 113.61±37.60 | ||
| FBS (mg/dl) | 108.80±30.91 | 102.25±28.81 | ||
| INS (mg/dl) | 15.51±6.08 | 19.47±13.31 | ||
| T. BILL (mg/d) | 1.08±0.52 | 0.91±0.36 | ||
| D.BILL (mg/d) | 0.25±0.15 | 0.24±0.20 | ||
The data were analyzed with two independent group t test for each characteristic, ALT: alanine aminotransferase, AST: aspartate transaminase, ALP: alkaline phosphatase, BMI: body mass index, TG: triglyceride, CHOL: total cholesterol, HDL: high density lipoprotein, LDL: low density lipoprotein, FBS: fasting blood sugar, INS: insulin, T.BILL: total bilirubin, D.BILL: direct bilirubin